NWBO Northwest Biotherapeutics Inc (QB)

• Puration (OTCPK:PURA +4.3%) announced that current conditions are strongly indicating that could lead to the company realizing more revenue than its forecasted $1M in 2022 in mid-November.
• The current outlook for the potential increase could lead to the company realizing up to $10M in revenue.
• The initial $1M in revenue forecasted for next year conservatively only encompasses revenue coming from its education line of business which is designed to ignite the revenue potential of the branding and partnership business lines.
• Management indicates the branding and particularly the partnership lines of business have a high potential of contributing revenue next year.

Source - https://seekingalpha.com/news/3780045-puration-sees-2022-revenue-upside-potential-to-10m?utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=RTA+News+Smart

Other stocks on the move include AABB, NWBO and NSAV

SOURCE: pennymillions